Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

DGAP-Adhoc: Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share


DGAP-Ad-hoc: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Forecast/Change in Forecast
Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share

24-Jul-2020 / 11:58 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Insider information pursuant to Article 17 MAR

Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share

Berlin, 24 July 2020. Based on initial, un-audited assessments, revenues and earnings of Berlin-based isotope specialists Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) for the half year ending 30 June 2020 are significantly higher than expected.

The consolidated result in the first half of the year should reach EUR 2.47 per share (Q2 previous year: EUR 2.59). At the same time sales should run to about EUR 84 million (Q2 previous year: EUR 89 million).

On the basis of this evaluation, and despite Corona, the Executive Board expects the consolidated result for the financial year 2020 to exceed the forecast published at the beginning of the year. It therefore rescinds the previous guidance and increases the target of EUR 3.50 to EUR 4.00 per share. The Executive Board keeps the revenue forecast at EUR 170 million.

The figures are based on the share capital as of 30 June 2020. Converted to the increased share capital of EUR 21,171,932, the forecast is EUR 1.00 per share.

The complete figures for the first half year 2020 will be published on 13 August 2020.

Your contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, [email protected], www.ezag.de


24-Jul-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: +49 30 941084-138
Fax: +49 30 941084-112
E-mail: [email protected]
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1100997

 
End of Announcement DGAP News Service

1100997  24-Jul-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1100997&application_name=news&site_id=sharewise

Eckert & Ziegler Strahlen- und Medizintechnik AG Aktie

45,78 €
-1,04 %
Eckert & Ziegler Strahlen- und Medizintechnik AG muss heute Verluste wegstecken. Die Aktie notiert im Vergleich zu gestern um -1,04 % tiefer.
Positive Tendenz für Eckert & Ziegler Strahlen- und Medizintechnik AG mit mehreren Buy- und keiner Sell-Einschätzung.
Das durchschnittliche Community-Kursziel von 95 € für Eckert & Ziegler Strahlen- und Medizintechnik AG deutet auf eine Verdopplung des aktuellen Kurses von 45.78 € hin.
Like: 0
Teilen
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Rechtlicher Hinweis

Kommentare